Diabetes

>

Latest News

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency | © Contemporary Pediatrics
FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

July 8th 2025

The FDA accepted Eton Pharmaceuticals' NDA for ET-600 for pediatric arginine vasopressin deficiency, with a target action date in February of 2026.

Third-trimester hyperglycemia in pregnancy linked to adult obesity in offspring | Image Credit: © lukszczepanski - stock.adobe.com.
Third-trimester hyperglycemia in pregnancy linked to adult obesity in children

June 23rd 2025

Diabetes device data may fail to deliver based on smartphone settings | Image Credit: © KRISTINA KUPTSEVICH - © KRISTINA KUPTSEVICH - stock.adobe.com.
Diabetes device data may fail to deliver based on smartphone settings

February 5th 2025

Image Credit: © Calin - stock.adobe.com
FDA approves first generic GLP-1 injection for type 2 diabetes in patients 10 years and up

December 23rd 2024

Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial | Image Credit: © Africa Studio - © Africa Studio - stock.adobe.com.
Afrezza inhaled insulin meets primary endpoint in phase 3 pediatric diabetes trial

December 20th 2024

More News

© 2025 MJH Life Sciences

All rights reserved.